IPO Monitor
Recent IPO Filings
Date Company Location Amount
2020-03-31 Harbor Custom Development, Inc. Gig Harbor, WA N/A
 A real estate development company
2020-03-25 GAN Ltd London, UNITED KINGDOM $35.0 mil.
 An award-winning provider of enterprise Software-as-a-Service (“SaaS”) solutions for online casino gaming
2020-03-18 UTime Ltd Shenzhen, CHINA $21.6 mil.
 Provides cost-effective mobile devices to consumers globally
2020-03-17 Sustainable Opportunities Acquisition Corp. Dallas, TX $300.0 mil.
 A newly incorporated blank check company
2020-03-16 Keros Therapeutics, Inc. Lexington, MA $86.3 mil.
 A clinical-stage biopharmaceutical company
2020-03-13 Brilliant Acquisition Corp Shanghai, CHINA $40.0 mil.
 A blank check company
2020-03-11 BioVie Inc. Los Angeles, CA $8.13 mil.
 A clinical-stage company
2020-03-09 Chardan Healthcare Acquisition 2 Corp. New York, NY $85.0 mil.
 A newly organized blank check company
2020-03-06 Ayala Pharmaceuticals, Inc. Rehovot, ISRAEL $50.0 mil.
 A clinical-stage oncology company
2020-03-06 CC Neuberger Principal Holdings I New York, NY $300.0 mil.
 A newly incorporated blank check company
2020-03-06 Zentalis Pharmaceuticals, LLC New York, NY $100.0 mil.
 A clinical-stage biopharmaceutical company
2020-03-06 Lyra Therapeutics, Inc. Watertown, MA $57.5 mil.
 A clinical-stage therapeutics company
2020-03-06 Fortress Value Acquisition Corp. New York, NY $300.0 mil.
 A newly incorporated blank check company
2020-03-06 Albertsons Companies, Inc. Boise, ID $100.0 mil.
 One of the largest food retailers in the United States,
2020-03-03 Roth CH Acquisition I Co Newport Beach, CA $75.0 mil.
 A blank check company
2020-03-02 Collective Growth Corp Austin, TX $150.0 mil.
 A newly organized blank check company
2020-03-02 Live Oak Acquisition Corp Great Falls, VA $200.0 mil.
 A blank check company
2020-02-28 Oric Pharmaceuticals, Inc. South San Francisco, CA $86.3 mil.
 A clinical-stage biopharmaceutical company
2020-02-28 Procore Technologies, Inc. Carpinteria, CA $100.0 mil.
 A leading provider of cloud-based construction management software
2020-02-28 NLS Pharmaceutics Ltd. Stans, SWITZERLAND $40.3 mil.
 An innovative biopharmaceutical company

[ Contact Us | About Us | Site Map ]

Copyright (c) 1998-2020 IPO Monitor. All rights reserved